Clinical Thyroidology for the Public Volume 10 Issue 5

Clinical Thyroidology for the Public summarizes selected research studies discussed in the previous month’s issue of Clinical Thyroidology, an official publication of the American Thyroid Association. Editor-in-chief, Alan Farwell, MD, FACE

Volume 10 Issue 5

International Thyroid Awareness Month

We welcome your feedback and suggestions. Let us know what you want to see in this publication.

Feedback & Suggestions

PDF Format for Saving and Printing
Clinical Thyroidology for the Public Volume 10 Issue 5 (PDF file, 1.22 MB)

TABLE OF CONTENTS Web Format

Editor’s Comments

THYROID AND PREGNANCY American Thyroid Association task force updates treatment guidelines for the diagnosis and management of thyroid disease during pregnancy and the postpartum
Alexander, Pearce, et al., 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum. Thyroid. DOI: 10.1089/thy.2016.0457
(PDF File for saving and printing, 536 KB)

HYPOTHYROIDISM Subclinical hypothyroidism and pregnancy outcomes
Maraka S et al, Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment. BMJ 2017;356:i6865.
(PDF File for saving and printing, 491 KB)

THYROID CANCER Pregnancy does not affect progression of thyroid cancer
Rakhlin L et al Response to therapy status is an excellent predictor of pregnancy-associated structural disease progression in patients previously treated for differentiated thyroid cancer. Thyroid. January 19, 2017 [Epub ahead of print].
(PDF File for saving and printing, 533 KB)

GRAVES’ DISEASE The “GREAT” score, a clinical tool that predicts the success of antithyroid drug therapy for Graves’ disease
Struja T et al, External validation of the GREAT score to predict relapse risk in Graves’ disease: results from a multicenter, retrospective study with 741 patients. Eur J Endocrinol. 2017;176:413-9.
(PDF File for saving and printing, 582 KB)

HYPERTHYROIDISM Radioactive iodine therapy has the most favorable profile for the treatment of Graves’ disease at the Mayo Clinic
Sundaresh V et al. Comparative effectiveness of treatment choices for Graves’ hyperthyroidism—a historical cohort study. Thyroid. Apr 2017, 27(4): 497-505.
(PDF File for saving and printing, 518 KB)

THYROID CANCER Treatment with surgery, external-beam radiation, and chemotherapy improves survival for selected patients with anaplastic thyroid cancer
Rao SN et al. Patterns of treatment failure in anaplastic thyroid carcinoma. Thyroid. January 9, 2017 [Epub ahead of print].
(PDF File for saving and printing, 495 KB)

ATA ALLIANCE FOR THYROID PATIENT EDUCATION

Thyroid Awareness Monthly Campaigns